An informational video for patients on how to use a home blood pressure monitor is available on the VA/DoD Clinical Practice 10 Home blood pressure monitoring video is available on the VA/DoD Clinical Practice Guidelines page at https://www.healthquality.va.gov/guidelines/cd/htn/index.asp; or directly at https://www.youtube.com/watch?v=IHY5MJc4Z_M&feature=youtu.be. As this is a Reviewed, New-added recommendation, the Work Group systematically reviewed evidence related to this recommendation in the evidence review conducted as part of this guideline update.[49-53] The Work Group s confidence in the quality of the evidence is very low due to the subjective outcome assessment, incomplete outcome data, selective reporting, lack of blinding, and recruitment bias. The body of evidence had some limitations including confounders in the analysis.[49-51,53] Other considerations regarding this recommendation included the benefits of improved blood pressure and increased participation in care, which outweigh the potential harms (none identified). Patient values and preferences were somewhat varied. Thus, the Work Group decided upon a Weak for recommendation. More research is needed on the specific co-intervention paired with HBPM to identify the most effective intervention. B. Treatment Goals and General Approaches to Hypertension Management a. Blood Pressure Goals Recommendation 6. For all patients, including those with type 2 diabetes, we suggest treating to a systolic blood pressure goal of <130 mm Hg. (Weak for | Reviewed, New-added) Discussion Pharmacologic treatment of HTN has been demonstrated to decrease the risk of major adverse cardiovascular events (MACE) such as CHD, stroke, heart failure, and overall mortality in patients with HTN, including patients with both HTN and diabetes.[54] Treatment of SBP to a goal of less than 130 mm Hg may lead to a reduction in cardiovascular events when compared to higher thresholds. The SR and meta-analysis by Ettehad et al. (2016) provides evidence in support of this recommendation.